Provided by Tiger Trade Technology Pte. Ltd.

Cogent

8.87
+0.20002.31%
Volume:474.24K
Turnover:4.14M
Market Cap:454.28M
PE:-9.42
High:8.91
Open:8.77
Low:8.56
Close:8.67
52wk High:45.69
52wk Low:8.56
Shares:51.22M
Float Shares:45.32M
Volume Ratio:0.72
T/O Rate:1.05%
Dividend:0.08
Dividend Rate:0.90%
EPS(TTM):-0.9421
EPS(LYR):-3.8009
ROE:-721.50%
ROA:-1.24%
PB:-13.31
PE(LYR):-2.33

Loading ...

Cogent Comms Hldgs Q1 EPS $(0.83) Beats $(0.95) Estimate, Sales $239.187M Miss $241.924M Estimate

Benzinga Earnings
·
May 04

Cogent Q1 FY26 net loss widens to $39.5 million; revenue falls 3.2% to $239.2 million

Reuters
·
May 04

BRIEF-Cogent Communications Q1 Basic EPS USD -0.83 Vs. IBES Estimate USD -1

Reuters
·
May 04

Cogent Communications Q1 Adjusted Gross Margin 46.1%

THOMSON REUTERS
·
May 04

Cogent Communications Q1 Ebitda USD 45.183 Million

THOMSON REUTERS
·
May 04

Cogent Communications Q1 Adjusted Ebitda USD 70.183 Million VS. Ibes Estimate USD 73.5 Million

THOMSON REUTERS
·
May 04

Cogent Communications Reports First Quarter 2026 Results

THOMSON REUTERS
·
May 04

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 04

Cogent Communications Holdings Inc expected to post a loss of 100 cents a share - Earnings Preview

Reuters
·
May 01

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 01

Earning Preview: Cogent Communications Holdings, Inc. revenue is expected to decrease by 3.60%, and institutional views are cautious

Earnings Agent
·
Apr 27

Cogent Biosciences Announces Oral Presentation of Positive Phase 3 PEAK Trial in Gastrointestinal Stromal Tumors (GIST) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire
·
Apr 21

A Look At Cogent Communications Holdings’s Valuation After Its Recent Share Price Rebound

Simply Wall St.
·
Apr 20

Cogent Communications Weighs Liquidity Risks Against Valuation Discount

Simply Wall St.
·
Apr 19

Cogent Biosciences Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026

GlobeNewswire
·
Apr 17

Cogent to host first-quarter earnings call May 4

Reuters
·
Apr 15

Cogent Communications to See 'Soft' Q1, 'Strong Rebound' in H2, Oppenheimer Says

MT Newswires Live
·
Apr 08

Cogent Biosciences submits bezuclastinib new drug application to the FDA

TIPRANKS
·
Apr 01

Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST)

GlobeNewswire
·
Apr 01

Cogent Biosciences Advances CGT6297 Into First-in-Human Trial for PIK3CA-Driven Cancers

TIPRANKS
·
Mar 28